Wire · opportunities
Exhaled Breath, Blood Tests Differentiate Lung Diseases
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 22 October 2026 · Fusion42 review
Research has identified distinct lipid signatures in blood plasma and exhaled breath samples that can noninvasively differentiate idiopathic pulmonary fibrosis (IPF) from fibrotic hypersensitivity pneumonitis (fHP). These lipid profiles also correlate with clinical indicators of disease severity, aiding better disease classification and management.
This Wire brief sits within Fusion42's coverage of Diagnostics and Biotech.
◆ ◆ The Wire takeaway
You now have a new noninvasive tool to tell apart two tough lung diseases using breath and blood markers. This opens a door to simpler, faster diagnostics that could speed up correct treatment decisions.
◆ Coverage
1 source · 21 Oct 2026
◆ Related on Wire
◆ Topics